These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection. Parkes MD; Halloran PF; Hidalgo LG Transplantation; 2017 Apr; 101(4):e102-e111. PubMed ID: 27906829 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies. Cai Q; Moore SA; Hendricks AR; Torrealba JR Transplant Proc; 2020 May; 52(4):1192-1197. PubMed ID: 32197864 [TBL] [Abstract][Full Text] [Related]
5. Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection. Afzali B; Chapman E; Racapé M; Adam B; Bruneval P; Gil F; Kim D; Hidalgo L; Campbell P; Sis B; Duong Van Huyen JP; Mengel M Am J Transplant; 2017 Feb; 17(2):496-505. PubMed ID: 27401781 [TBL] [Abstract][Full Text] [Related]
7. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant. Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931 [TBL] [Abstract][Full Text] [Related]
8. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies. Frank R; Dean SA; Molina MR; Kamoun M; Lal P Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957 [TBL] [Abstract][Full Text] [Related]
9. Compartment-specific expression of natural killer cell markers in renal transplantation: immune profile in acute rejection. Dos Santos DC; Campos EF; Saraiva Câmara NO; David DS; Malheiros DM Transpl Int; 2016 Apr; 29(4):443-52. PubMed ID: 26615051 [TBL] [Abstract][Full Text] [Related]
10. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study. Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425 [TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies. Gupta A; Broin PÓ; Bao Y; Pullman J; Kamal L; Ajaimy M; Lubetzky M; Colovai A; Schwartz D; de Boccardo G; Golden A; Akalin E Kidney Int; 2016 Jan; 89(1):217-25. PubMed ID: 26422506 [TBL] [Abstract][Full Text] [Related]
12. Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens. Xu L; Collins J; Drachenberg C; Kukuruga D; Burke A Clin Transplant; 2014 May; 28(5):554-60. PubMed ID: 24580037 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts. Li F; Wei J; Valenzuela NM; Lai C; Zhang Q; Gjertson D; Fishbein MC; Kobashigawa JA; Deng M; Reed EF J Heart Lung Transplant; 2015 Apr; 34(4):580-587. PubMed ID: 25511749 [TBL] [Abstract][Full Text] [Related]
14. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy. Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449 [TBL] [Abstract][Full Text] [Related]
15. Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies. Hayde N; Broin PÓ; Bao Y; de Boccardo G; Lubetzky M; Ajaimy M; Pullman J; Colovai A; Golden A; Akalin E Kidney Int; 2014 Sep; 86(3):600-9. PubMed ID: 24670411 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation. Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694 [TBL] [Abstract][Full Text] [Related]
17. Early screening for antibody-mediated rejection in heart transplant recipients. Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477 [TBL] [Abstract][Full Text] [Related]
18. Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection. Adam N; Coutance G; Viailly PJ; Drieux F; Ruminy P; Sater AA; Toquet C; Rouvier P; François A; Chenard MP; Epailly E; Guillemain R; Pattier S; Gay A; Varnous S; Taupin JL; Rabant M; Loupy A; Bruneval P; Duong Van Huyen JP J Heart Lung Transplant; 2020 Feb; 39(2):115-124. PubMed ID: 31822443 [TBL] [Abstract][Full Text] [Related]